These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 3006391

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The molecular journey from ductal carcinoma in situ to invasive breast cancer.
    Wiechmann L, Kuerer HM.
    Cancer; 2008 May 15; 112(10):2130-42. PubMed ID: 18383519
    [Abstract] [Full Text] [Related]

  • 31. [Radiotherapy of breast carcinoma. 2005 version].
    Organgruppe "Mammakarzinom" der DEGRO.
    Strahlenther Onkol; 2006 Feb 15; 182 Suppl 1():4-28. PubMed ID: 16613299
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Prognostic significance of tumor grading in breast cancer].
    Reiner A, Holzner JH, Reiner G, Spona J, Schemper M, Kolb R, Jakesz R.
    Verh Dtsch Ges Pathol; 1985 Feb 15; 69():365-9. PubMed ID: 3006387
    [No Abstract] [Full Text] [Related]

  • 34. [Immunocytochemical demonstration of actin in myothelial cells in proliferative diseases of the breast].
    Walther B, Rutter G, Stegner HE, Böcker W.
    Pathologe; 1986 Nov 15; 7(6):318-23. PubMed ID: 3027685
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [A case of carcinoma of the breast with squamous and cartilaginous metaplasia].
    Hayashi I, Katsuda Y, Nomura Y, Tashiro H, Ookuma T.
    Gan No Rinsho; 1984 Dec 15; 30(15):1924-30. PubMed ID: 6098748
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Ductal carcinoma in situ: progression to invasive cancer is slow and only occurs in a minority of case.
    Prescrire Int; 2013 Dec 15; 22(144):301. PubMed ID: 24600735
    [Abstract] [Full Text] [Related]

  • 39. [Pathological findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ)].
    Haase W.
    Strahlenther Onkol; 1996 Feb 15; 172(2):109-10. PubMed ID: 8669043
    [No Abstract] [Full Text] [Related]

  • 40. Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome.
    Mazouni C, Peintinger F, Wan-Kau S, Andre F, Gonzalez-Angulo AM, Symmans WF, Meric-Bernstam F, Valero V, Hortobagyi GN, Pusztai L.
    J Clin Oncol; 2007 Jul 01; 25(19):2650-5. PubMed ID: 17602071
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.